The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to this ability, the share of CRISPR/Cas9 is incessantly increasing in the Genome Editing Industry. It is anticipated that the global CRISPR/Cas9 market will cross US$ 1.5 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications and increasing research related activities for exploring CRISPR/Cas9 therapeutic applications.
The report, “Global CRISPR/Cas9 Market Outlook 2022”, provides an insight into the current and future prospective of this market. This report covers the major opportunities in this area, and drivers that have impact on the market. The report also discusses some of the challenges currently faced by the market.
The major application areas of CRISPR/Cas9 include cell line engineering, genetic engineering, CRISPR plasmid development, human stem cells, gene library development and producing GM organisms or crops. Cell Line Engineering is the largest area of application of CRISPR/Cas9, followed by Genetic Engineering. This large share can be attributed to extensibility and multiplexity of CRISPR/Cas9 in modifying the multiple sites within the mammalian genome. The genetic engineering market employing CRISPR/Cas9 is expected to witness the highest growth in 2016-2022. This growth is likely to be driven by reduction of evolutionary time in comparison to previous gene editing tools, such as Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs).
Moreover, the report also contains the market share of major regions, including North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Japan, which is expanding CRISPR applications to developmental biology. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in these market. The report also provides market share for the rest of the world which includes regions such as Africa, Latin America, Argentina, etc.
The last segment of the report is entirely devoted to profiling leading companies of the CRISPR/Cas9 industry, including some major players like Thermo Fisher Scientific, Lonza, Agilent Technologies, GenScript, Editas Medicine, Horizon Discovery, etc. This segment provides access to the financials, product portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global CRISPR/Cas9 market.
Our reports have been used by over 10K customers, including:
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
168 pages •
By Global Industry Analysts
• Mar 2021
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 6
- Influencer Pool: 909
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
Transcriptomics Technologies Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Transcriptomics Technologies market including the COVID-19 pandemic...
178 pages •
By Global Industry Analysts
• Sep 2020
Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray,...
This study covers the world outlook for ribonucleic acid (RNA) analysis and transcriptomics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...
187 pages •
By Global Industry Analysts
• Oct 2019
Transcriptomics market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.